Clinical Trial Update: Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing labeled dosing versus a treat-and-extend regimen in Turkish patients with choroidal neovascularization due to age-related macular dege…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Age-related Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2013-05-20